Spots Global Cancer Trial Database for metastatic ovarian cancer
Every month we try and update this database with for metastatic ovarian cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer | NCT03287674 | Metastatic Ovar... | Cyclophosphamid... Fludarabine TIL infusion Interleukin-2 Ipilimumab Nivolumab | 18 Years - 70 Years | Herlev Hospital | |
| EDMONd - Elemental Diet in Bowel Obstruction | NCT03150992 | Ovarian Cancer Ovarian Neoplas... Ovarian Disease Peritoneal Neop... Peritoneal Dise... Metastatic Ovar... Primary Periton... Abdominal Neopl... Bowel Obstructi... | Elemental 028 E... | 18 Years - 90 Years | Royal Surrey County Hospital NHS Foundation Trust | |
| Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer | NCT01768156 | Metastatic Ovar... | Experimental ar... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers | NCT02179970 | Pancreatic Aden... Ovarian Serous ... Colorectal Canc... | Plerixafor | 16 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers | NCT00319748 | Breast Cancer Ovarian Cancer Endometrial Can... Cervical Cancer | 852A | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers | NCT02179970 | Pancreatic Aden... Ovarian Serous ... Colorectal Canc... | Plerixafor | 16 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian | NCT03412526 | Metastatic Ovar... | Fludarabine Radiation TIL administrat... IL-2 | 18 Years - 80 Years | Sheba Medical Center | |
| Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer | NCT03634150 | Metastatic Ovar... Triple Negative... | Nerofe is a fir... | 18 Years - 90 Years | Immune System Key Ltd | |
| Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer | NCT03634150 | Metastatic Ovar... Triple Negative... | Nerofe is a fir... | 18 Years - 90 Years | Immune System Key Ltd | |
| T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer | NCT04611126 | Metastatic Ovar... Metastatic Fall... Peritoneal Canc... | Ipilimumab Cyclophosphamid Fludarabine Pho... Tumor Infiltrat... Nivolumab Relatlimab | 18 Years - 75 Years | Herlev Hospital | |
| Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer | NCT03277482 | Recurrent Gynec... Metastatic Cerv... Metastatic Ovar... Metastatic Vagi... Metastatic Vulv... Metastatic Endo... Recurrent Cervi... Recurrent Ovari... Recurrent Vagin... Recurrent Vulva... Recurrent Endom... | Durvalumab Tremelimumab Radiation Thera... | 18 Years - | Dana-Farber Cancer Institute | |
| TIL Therapy for Metastatic Ovarian Cancer | NCT02482090 | Metastatic Ovar... | Cyclophosphamid... Fludarabine TIL infusion Interleukin-2 | 18 Years - 70 Years | Herlev Hospital | |
| Measuring Oncological Value of Exercise and Statin | NCT05796973 | Prostate Cancer Breast Cancer Kidney Cancer Ovarian Cancer Metastatic Brea... Metastatic Kidn... Metastatic Rena... Metastatic Rena... Metastatic Pros... Metastatic Pros... Metastatic Ovar... Metastatic Ovar... | Guided physical... Atorvastatin Independent exe... | 18 Years - 99 Years | Tampere University Hospital | |
| Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer | NCT03634150 | Metastatic Ovar... Triple Negative... | Nerofe is a fir... | 18 Years - 90 Years | Immune System Key Ltd | |
| Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers | NCT00319748 | Breast Cancer Ovarian Cancer Endometrial Can... Cervical Cancer | 852A | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| [18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging | NCT03242993 | Metastatic Canc... Metastatic Ovar... | [18F]-AzaFol folarell | 18 Years - | University of Lausanne Hospitals | |
| TIL Therapy for Metastatic Ovarian Cancer | NCT02482090 | Metastatic Ovar... | Cyclophosphamid... Fludarabine TIL infusion Interleukin-2 | 18 Years - 70 Years | Herlev Hospital | |
| EDMONd - Elemental Diet in Bowel Obstruction | NCT03150992 | Ovarian Cancer Ovarian Neoplas... Ovarian Disease Peritoneal Neop... Peritoneal Dise... Metastatic Ovar... Primary Periton... Abdominal Neopl... Bowel Obstructi... | Elemental 028 E... | 18 Years - 90 Years | Royal Surrey County Hospital NHS Foundation Trust |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
